Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

- PMLiVE

Galderma’s Nemluvio rapidly relieves atopic dermatitis and prurigo nodularis symptoms

Some patients found the treatment reduced itch and sleep disturbance within just two days

- PMLiVE

Pharma’s digital dilemma: Finding the balance between speed, scale, and experience

What’s holding pharma back from true digital transformation? At NEXT Pharma 2025, Our CEO Rob Verheul and Roeland van der Heiden (AstraZeneca) argued it starts with design systems. This quick...

Graphite Digital

- PMLiVE

PMLiVE’s T40 2025 – results announced!

Find out which agencies came top and which agencies are among the big climbers in this year’s list

- PMLiVE

Nektar Therapeutics announces top-line results from alopecia areata study

This autoimmune disease causes hair loss in both women and men, affecting 160 million people worldwide

- PMLiVE

Havas Life London unveils AI awareness campaign

The campaign highlights the dangers of AI misinformation in rare disease

- PMLiVE

The next era in life sciences: agentic AI and other innovations transforming HCP engagement

By Chris Moore

- PMLiVE

Scaling AI in healthcare communications: from pilots to living systems

By Andreas Reinbolz and Thomas Nisters

- PMLiVE

Clicks vs credibility: how social media underscores patient understanding

By Jordan Brand

- PMLiVE

Launch differently: how unforgettable brands break through

By Whitney Morley and Jo Crouch

- PMLiVE

Predicting the future of health equity in the pharmaceutical industry

By Natalia Barkalina and Noah Froud

- PMLiVE

How smart scaling and strategic implementation of AI are transforming life sciences

By Jo Ann Saitta

- PMLiVE

Redefining digital ROI: Engagement, experience, and the new metrics of success

Clicks and engagement only tell part of the story. In this webinar, pharma leaders discuss how to move beyond traditional KPIs to measure real impact and ROI from digital and...

Graphite Digital

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links